Esbitt Sabrina A, Batchelder Abigail W, Tanenbaum Molly L, Shreck Erica, Gonzalez Jeffrey S
Ferkauf Graduate School of Psychology, Yeshiva University.
Ferkauf Graduate School of Psychology, Yeshiva University, and Albert Einstein College of Medicine, Yeshiva University.
Cogn Behav Pract. 2015 Aug 1;22(3):393-406. doi: 10.1016/j.cbpra.2014.02.006.
Depression and illness-specific distress are more common among adults with Type 1 diabetes (T1DM) than the general population and have been associated with poorer control of blood glucose and increased risk for serious diabetes-related complications. Treatment nonadherence has also been associated with depressive symptoms and diabetes-related distress, and has repeatedly been suggested as an important modifiable behavioral pathway linking depression and diabetes outcomes. The present study reports on the feasibility and acceptability of a pilot intervention using group-based cognitive-behavioral therapy to improve treatment adherence among adults with T1DM and elevated levels of diabetes-related distress or depressive symptoms. We describe the components of the intervention and utilize qualitative data along with descriptive outcome data. Our findings suggest that participation in the group was acceptable and associated with reductions in depressive symptoms and diabetes-specific distress. Challenges to feasibility and future directions are discussed.
与普通人群相比,抑郁症和特定疾病困扰在1型糖尿病(T1DM)成人患者中更为常见,并且与血糖控制不佳以及严重糖尿病相关并发症风险增加有关。治疗依从性差也与抑郁症状和糖尿病相关困扰有关,并且反复被认为是连接抑郁症和糖尿病结局的重要可改变行为途径。本研究报告了一项试点干预措施的可行性和可接受性,该干预措施采用基于小组的认知行为疗法来提高T1DM成人患者的治疗依从性,这些患者的糖尿病相关困扰或抑郁症状水平较高。我们描述了干预措施的组成部分,并利用定性数据以及描述性结果数据。我们的研究结果表明,参与该小组是可以接受的,并且与抑郁症状和糖尿病特异性困扰的减少有关。讨论了可行性挑战和未来方向。